Patents by Inventor John Bernard Buse

John Bernard Buse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Integrated sample acquisition and analyte measurement method
    Patent number: 9662057
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Grant
    Filed: February 17, 2016
    Date of Patent: May 30, 2017
    Assignee: Abbott Diabetes Care Inc.
    Inventors: John Bernard Buse, Alan Charles Moses
  • Integrated Sample Acquisition and Analyte Measurement Device
    Publication number: 20160235350
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Application
    Filed: February 17, 2016
    Publication date: August 18, 2016
    Inventors: John Bernard Buse, Alan Charles Moses
  • Method for integrated sample acquisition and analyte measurement device
    Patent number: 9271669
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Grant
    Filed: April 27, 2015
    Date of Patent: March 1, 2016
    Assignee: Abbott Diabetes Care Inc.
    Inventors: John Bernard Buse, Alan Charles Moses
  • Integrated Sample Acquisition and Analyte Measurement Device
    Publication number: 20150245791
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Application
    Filed: April 27, 2015
    Publication date: September 3, 2015
    Inventors: John Bernard Buse, Alan Charles Moses
  • Integrated sample acquisition and analyte measurement device
    Patent number: 9017259
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Grant
    Filed: August 5, 2014
    Date of Patent: April 28, 2015
    Assignee: Abbott Diabetes Care Inc.
    Inventors: John Bernard Buse, Alan Charles Moses
  • Integrated Sample Acquisition and Analyte Measurement Device
    Publication number: 20150018655
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Application
    Filed: August 5, 2014
    Publication date: January 15, 2015
    Inventors: John Bernard Buse, Alan Charles Moses
  • Integrated sample acquisition and analyte measurement device
    Patent number: 8795176
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Grant
    Filed: July 30, 2007
    Date of Patent: August 5, 2014
    Assignee: Abbott Diabetes Care Inc.
    Inventors: John Bernard Buse, Alan Charles Moses
  • Methods of determining analyte concentration
    Patent number: 8532731
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: September 10, 2013
    Assignee: Abbott Diabetes Care Inc.
    Inventors: John Bernard Buse, Alan Charles Moses
  • Methods of determining concentration of glucose
    Patent number: 7740581
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Grant
    Filed: September 29, 2005
    Date of Patent: June 22, 2010
    Assignee: Abbott Diabetes Care Inc.
    Inventors: John Bernard Buse, Alan Charles Moses
  • METHODS OF DETERMINING CONCENTRATION OF KETONE BODIES
    Publication number: 20090270764
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Application
    Filed: May 8, 2009
    Publication date: October 29, 2009
    Inventors: John Bernard Buse, Alan Charles Moses
  • Methods of determining concentration of glucose
    Patent number: 7058437
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Grant
    Filed: April 17, 2003
    Date of Patent: June 6, 2006
    Assignee: TheraSense, Inc.
    Inventors: John Bernard Buse, Alan Charles Moses
  • Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
    Publication number: 20030199744
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Application
    Filed: April 17, 2003
    Publication date: October 23, 2003
    Applicant: TheraSense, Inc.
    Inventors: John Bernard Buse, Alan Charles Moses
  • Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
    Patent number: 6591125
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Grant
    Filed: June 27, 2000
    Date of Patent: July 8, 2003
    Assignee: TheraSense, Inc.
    Inventors: John Bernard Buse, Alan Charles Moses